These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36787816)

  • 1. Transarterial Radioembolization Ought Not to Borrow Future Liver Function from Patients with Hepatocellular Carcinoma. But Does It?
    Sangro B; Argemí J
    J Vasc Interv Radiol; 2023 Jun; 34(6):976-977. PubMed ID: 36787816
    [No Abstract]   [Full Text] [Related]  

  • 2. How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide.
    Denys A; Pracht M; Duran R; Guiu B; Adib S; Boubaker A; Bize P
    Cardiovasc Intervent Radiol; 2015 Aug; 38(4):794-805. PubMed ID: 25828724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablative Radioembolization of a Synchronous Renal Cell Carcinoma and Hepatocellular Carcinoma.
    McGregor H; Laidlaw G; Johnson G
    J Vasc Interv Radiol; 2023 Oct; 34(10):1847-1849. PubMed ID: 37391075
    [No Abstract]   [Full Text] [Related]  

  • 4. Coil-Assisted Temporary Vascular Occlusion to Protect Tumor-Free Territory during Transarterial Radioembolization.
    Park JJ; Boas FE
    J Vasc Interv Radiol; 2024 Jun; 35(6):929-931. PubMed ID: 38789206
    [No Abstract]   [Full Text] [Related]  

  • 5. Focus on Uniformity, Not Dose: The Folly of Yttrium-90 Transarterial Radioembolization Dose-Escalation Studies.
    Nuffer Z
    J Vasc Interv Radiol; 2024 Jun; 35(6):918-919. PubMed ID: 38447769
    [No Abstract]   [Full Text] [Related]  

  • 6. Perspectives for yttrium-90 radioembolization as therapeutic option for hepatocellular carcinoma.
    Burrel M; Bermúdez P; Forner González A
    Rev Esp Enferm Dig; 2022 Apr; 114(4):195-197. PubMed ID: 35315679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
    Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS
    J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.
    Ahmed AF; Samreen N; Grajo JR; Zendejas I; Sistrom CL; Collinsworth A; Esnakula A; Shah JL; Cabrera R; Geller BS; Toskich BB
    Abdom Radiol (NY); 2018 Jul; 43(7):1825-1836. PubMed ID: 29052747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
    Wehrenberg-Klee E; Gandhi RT; Ganguli S
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.
    Reiner CS; Morsbach F; Sah BR; Puippe G; Schaefer N; Pfammatter T; Alkadhi H
    J Vasc Interv Radiol; 2014 May; 25(5):747-59. PubMed ID: 24630751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Center Comparison of Overall Survival and Toxicities in Patients with Infiltrative Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization or Drug-Eluting Embolic Transarterial Chemoembolization.
    McDevitt JL; Alian A; Kapoor B; Bennett S; Gill A; Levitin A; Sands M; Narayanan Menon KV; Aucejo FN; Estfan B; Pillai AK; Kalva SP; McLennan G
    J Vasc Interv Radiol; 2017 Oct; 28(10):1371-1377. PubMed ID: 28689934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.
    Salem R; Mazzaferro V; Sangro B
    Hepatology; 2013 Dec; 58(6):2188-97. PubMed ID: 23512791
    [No Abstract]   [Full Text] [Related]  

  • 14. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
    Toskich BB; Liu DM
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):100-111. PubMed ID: 31079706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
    Hickey RM; Lewandowski RJ; Salem R
    Semin Nucl Med; 2016 Mar; 46(2):105-8. PubMed ID: 26897714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of Hepatocellular Carcinoma Response After
    Semaan S; Makkar J; Lewis S; Chatterji M; Kim E; Taouli B
    AJR Am J Roentgenol; 2017 Nov; 209(5):W263-W276. PubMed ID: 29072955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial Radioembolization for Hepatocellular Carcinoma and Hepatic Metastases: Clinical Aspects and Dosimetry Models.
    Mikell JK; Dewaraja YK; Owen D
    Semin Radiat Oncol; 2020 Jan; 30(1):68-76. PubMed ID: 31727302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE).
    Spreafico C; Maccauro M; Mazzaferro V; Chiesa C
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):634-8. PubMed ID: 24477451
    [No Abstract]   [Full Text] [Related]  

  • 19. Ablative Transarterial Radioembolization of a Parasitized Adrenal Artery for the Treatment of Hepatocellular Carcinoma.
    Vidal LLC; Frey GT; Ritchie C; Lewis A; Paz-Fumagalli R; McKinney M; Toskich BB
    J Vasc Interv Radiol; 2019 Mar; 30(3):473-476. PubMed ID: 30819498
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.
    Alem Z; Murray TE; Egri C; Chung J; Liu D; Elsayes KM; Chang SD; Harris A
    Abdom Radiol (NY); 2021 Aug; 46(8):3596-3614. PubMed ID: 33909092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.